Anthrax Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Cell-free PA Vaccines, Live Vaccines), By End-User(Specialty Center, Hospitals, Others), By Distribution Channel And Region Forecasts, 2023 - 2032
Report Description
According to estimates, the market for anthrax vaccines would be worth USD 10.14 billion in 2022 and USD 14.83 billion in 2032, growing at a CAGR of 11.6% between 2023 and 2032.
Market Dynamics
Because of the increased occurrence of anthrax, the vaccine industry is quickly rising. The growing habit of consuming raw and uncooked meat from sick animals is a key driving force in the global industry. Furthermore, an increase in the manufacture and industrialized processing of infected animal commodities such as wool, hair, and hide boosts market development considerably. Anthrax is more common in wild wildlife and cattle. The percentage of rural is growing as animal farming becomes more popular across the world. Individuals working on farms come into close contact with animals and are thus at significant risk of contracting anthrax. This aspect is a major market-main driver.
Furthermore, the cost-effectiveness of vaccines, new funding possibilities from the administration, research foundations, and contributors, as well as advancements in manufacturing and development technologies, are expected to drive market expansion throughout the projected period. Furthermore, the availability of a big target audience in developing regions fuels market expansion. However, because of the low percentage of voluntarily testing for anthrax illness, the industry for anthrax vaccines may experience a significant increase. Furthermore, a lack of knowledge regarding anthrax diagnostics in nations such as Africa renders it difficult for enterprises to directly approach their clients in such nations and areas, hampered market growth.
The worldwide anthrax vaccines industry is divided into five regions. The North American industry for anthrax vaccinations is the largest. In respect of income, the United States dominates the North American market. The European market is quickly rising because to a growing population of patients, particularly in the United Kingdom and Germans. Asia - Pacific region and Latin American markets are expected to grow considerably in the foreseeable future. Emerging countries including India and China are expected to support the growth of the Apac Region among 2020 and 2025, mainly due to better healthcare facilities, wealth creation, a rise in the amount of health coverage payers, the expansion of the personal healthcare industry, and increased awareness in these nations.
The Anthrax Vaccine market is fragmented into the Vaccine Type, application, end-user, and Distribution Channel segments. Based on the Vaccine Type, the cell-free PA vaccine is anticipated to dominate the market over the forecast period. Based on application, as a large number of anthrax vaccinations are used for livestock, the animal usage sector leads the anthrax vaccine industry. Up to 20percent of anthrax infections in humans result in mortality. As a result, the animal usage segment has expanded. In terms of the end-use segment, the hospital segment dominated the global market and is anticipated to continue its dominance over the forecast period.
The anthrax vaccine industry is concentrated, with only a few companies in both the people and veterinary segments. Major players lead the industry in respect of market size. With the growing frequency of illness and awareness campaigns, several new companies may come into the market throughout the projection period.
The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses market size and forecast of Anthrax Vaccines by Vaccine Type, region, End-user, Distribution Channel, and application. In addition, this report introduces the market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.):
- Merck & Co., Inc.,
- Emergent Bio-Solutions
- Zoetis, Inc.
- PharmAthene, Inc
- Biogenesis Bago S.A
- Porton Biopharma Limited
- Colorado Serum
- Merial, Inc.
- Tiankang
- Agrovet
- Biogenesis Bago
- Bayer AG
- Indian Immunologics
Vaccine Type Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Cell-free PA Vaccines
- Live Vaccines
End-user Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Specialty Center
- Hospitals
- Others
Distribution Channel Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Retail Pharmacy
- Hospital Pharmacy
- Others
Application Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):
- Animal Use
- Human Use
Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):
- North America (U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain, etc.)
- Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
- South America (Brazil, Mexico, Argentina, etc.)
- Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa, etc.)
Table Of Content
TABLE OF CONTENT
1. Anthrax Vaccine Market Overview
1.1. Product Overview and Scope of Anthrax Vaccine
1.2. Global Market Growth Prospects and Revenue Estimates
1.3. Global Anthrax Vaccine Market Size Growth Rate Analysis by Vaccine Type 2020 VS 2027
1.3.1. Cell-free PA Vaccines
1.3.2. Live Vaccines
1.4. Global Anthrax Vaccine Consumption Comparison by Application: 2020 VS 2027
1.4.1. Animal Use
1.4.2. Human Use
1.5. Global Anthrax Vaccine Consumption Comparison by End-user: 2020 VS 2027
1.5.1. Specialty Center
1.5.2. Hospitals
1.5.3. Others
1.6. Global Anthrax Vaccine Consumption Comparison by Distribution Channel: 2020 VS 2027
1.6.1. Retail Pharmacy
1.6.2. Hospital Pharmacy
1.6.3. Others
1.7. Global Anthrax Vaccine Market Size Estimates and Forecasts by Region: 2020 VS 2027
1.7.1. North America Anthrax Vaccine Estimates
1.7.2. Europe Anthrax Vaccine Estimates
1.7.3. China Anthrax Vaccine Estimates
1.7.4. Japan Anthrax Vaccine Estimates
2. Market Competition by Manufacturers
2.1. Global Anthrax Vaccine Revenue Market Share by Manufacturers (2020)
2.2. Anthrax Vaccine Market Share by Company Vaccine Type (Tier 1, Tier 2 and Tier 3)
2.3. Global Anthrax Vaccine Average Price by Manufacturers (2016-2021)
2.4. Manufacturers Anthrax Vaccine Production Sites, Area Served, Product Types
2.5. Anthrax Vaccine Market Competitive Situation and Trends
2.5.1. Anthrax Vaccine Market Concentration Rate
2.5.2. Mergers & Acquisitions, Expansion
3. Global Anthrax Vaccine Consumption by Region (2016-2021)
3.1. Global Anthrax Vaccine Consumption by Region
3.2. Global Anthrax Vaccine Consumption Market Share by Region
3.2.1. North America
3.2.2. North America Anthrax Vaccine Consumption Growth Rate (2016-2021)
3.2.3. North America Anthrax Vaccine Consumption, Price and Gross Margin (2016-2021)
3.2.4. North America Anthrax Vaccine Consumption by Country
3.2.4.1. U.S.
3.2.4.2. Canada
3.2.5. Europe
3.2.6. Europe Anthrax Vaccine Consumption Growth Rate (2016-2021)
3.2.7. Europe Anthrax Vaccine Consumption, Price and Gross Margin (2016-2021)
3.2.8. Europe Anthrax Vaccine Consumption by Country
3.2.8.1. Germany
3.2.8.2. U.K.
3.2.8.3. France
3.2.8.4. Italy
3.2.8.5. Spain
3.2.9. Asia Pacific
3.2.10. Asia Pacific Anthrax Vaccine Consumption Growth Rate (2016-2021)
3.2.11. Asia Pacific Anthrax Vaccine Consumption, Price and Gross Margin (2016-2021)
3.2.12. Asia Pacific Anthrax Vaccine Consumption by Country
3.2.12.1. China
3.2.12.2. India
3.2.12.3. Japan
3.2.12.4. Indonesia
3.2.12.5. Malaysia
3.2.12.6. Australia
3.2.12.7. South Korea
3.2.13. South America
3.2.14. South America Anthrax Vaccine Consumption Growth Rate (2016-2021)
3.2.15. South America Anthrax Vaccine Consumption, Price and Gross Margin (2016-2021)
3.2.16. South America Anthrax Vaccine Consumption by Country
3.2.16.1. Brazil
3.2.16.2. Mexico
3.2.16.3. Argentina
3.2.17. Middle East and Africa
3.2.18. Middle East and Africa Anthrax Vaccine Consumption Growth Rate (2016-2021)
3.2.19. Middle East and Africa Anthrax Vaccine Consumption, Price and Gross Margin (2016-2021)
3.2.20. Middle East and Africa Anthrax Vaccine Consumption by Country
3.2.20.1. Saudi Arabia
3.2.20.2. Kuwait
3.2.20.3. UAE
3.2.20.4. South Africa
4. Global Anthrax Vaccine Consumption by Vaccine Type (2016-2021)
4.1. Global Anthrax Vaccine Price by Vaccine Type (2016-2021)
4.2. Global Anthrax Vaccine Revenue Market Share by Vaccine Type (2016-2021)
4.2.1. Cell-free PA Vaccines
4.2.2. Live Vaccines
5. Global Anthrax Vaccine Consumption by Application (2016-2021)
5.1. Global Anthrax Vaccine Price by Application (2016-2021)
5.2. Global Anthrax Vaccine Revenue Market Share by Application (2016-2021)
5.2.1. Animal Use
5.2.2. Human Use
6. Global Anthrax Vaccine Consumption by End-user (2016-2021)
6.1. Global Anthrax Vaccine Price by End-user (2016-2021)
6.2. Global Anthrax Vaccine Revenue Market Share by End-user (2016-2021)
6.2.1. Specialty Center
6.2.2. Hospitals
6.2.3. Others
7. Global Anthrax Vaccine Consumption by Distribution Channel (2016-2021)
7.1. Global Anthrax Vaccine Price by Distribution Channel (2016-2021)
7.2. Global Anthrax Vaccine Revenue Market Share by Distribution Channel (2016-2021)
7.2.1. Retail Pharmacy
7.2.2. Hospital Pharmacy
7.2.3. Others
8. Key Companies Profiled
8.1. Merck & Co., Inc.
8.1.1. Merck & Co., Inc. Anthrax Vaccine Corporation Information
8.1.2. Merck & Co., Inc. Anthrax Vaccine Product Portfolio
8.1.3. Merck & Co., Inc. Anthrax Vaccine Consumption, Price and Gross Margin (2016-2021)
8.1.4. Merck & Co., Inc. Main Business and Markets Served
8.1.5. Merck & Co., Inc. Recent Developments/Updates
8.2. Emergent Bio-Solutions
8.3. Zoetis, Inc.
8.4. PharmAthene, Inc
8.5. Biogenesis Bago S.A
8.6. Porton Biopharma Limited
8.7. Colorado Serum
8.8. Merial, Inc.
8.9. Tiankang
8.10. Agrovet
8.11. Biogenesis Bago
8.12. Bayer AG
8.13. Indian Immunologics
9. Marketing Channel, Distributors and Customers
9.1. Marketing Channel
9.2. Anthrax Vaccine Distributors List
9.3. Anthrax Vaccine Customers
10. Market Dynamics
10.1. Anthrax Vaccine Industry Trends
10.2. Anthrax Vaccine Growth Drivers
10.3. Anthrax Vaccine Market Challenges
10.4. Anthrax Vaccine Market Restraints
11. Global Anthrax Vaccine Consumption and Demand Forecast, by Region (2022-2027)
11.1. Global Forecasted Demand Analysis of Anthrax Vaccine, by Regions and Country
11.1.1. North America Forecasted Consumption of Anthrax Vaccine by Country
11.1.2. Europe Market Forecasted Consumption of Anthrax Vaccine by Country
11.1.3. Asia Pacific Market Forecasted Consumption of Anthrax Vaccine by Region
11.1.4. Latin America Forecasted Consumption of Anthrax Vaccine by Country
11.1.5. Middle East and Africa Forecasted Consumption of Anthrax Vaccine by Country
12. Global Anthrax Vaccine Consumption and Demand Forecast, by End-user Segments (2022-2027)
12.1. Global Forecasted Consumption of Anthrax Vaccine by End-user Segments (2022-2027)
12.2. Global Consumption and Price Forecast by End-user Segments (2022-2027)
12.3. Global Forecasted Growth Rate of Anthrax Vaccine by End-user Segments (2022-2027)
13. Global Anthrax Vaccine Consumption and Demand Forecast, by Distribution Channel Segments (2022-2027)
13.1. Global Forecasted Consumption of Anthrax Vaccine by Distribution Channel Segments (2022-2027)
13.2. Global Consumption and Price Forecast by Distribution Channel Segments (2022-2027)
13.3. Global Forecasted Growth Rate of Anthrax Vaccine by Distribution Channel Segments (2022-2027)
14. Global Anthrax Vaccine Consumption and Demand Forecast, by Application Segments (2022-2027)
14.1. Global Forecasted Consumption of Anthrax Vaccine by Application Segments (2022-2027)
14.2. Global Consumption and Price Forecast by Application Segments (2022-2027)
14.3. Global Forecasted Growth Rate of Anthrax Vaccine by Application Segments (2022-2027)
15. Global Anthrax Vaccine Consumption and Demand Forecast, by Vaccine Type Segments (2022-2027)
15.1. Global Forecasted Consumption of Anthrax Vaccine by Vaccine Type Segments (2022-2027)
15.2. Global Consumption and Price Forecast by Vaccine Type Segments (2022-2027)
15.3. Global Forecasted Growth Rate of Anthrax Vaccine by Vaccine Type Segments (2022-2027)
16. Research Finding and Conclusion
17. Methodology and Data Source
17.1. Methodology/Research Approach
17.1.1. Research Programs/Vaccine Type
17.1.2. Market Size Estimation
17.1.3. Market Breakdown and Data Triangulation
17.2. Data Source
17.2.1. Secondary Sources
17.2.2. Primary Sources
17.3. Author List
17.4. Disclaimer
Research Methodology
Our research studies are primarily performed in five phases which include Secondary Research, Primary Research, Subject Matter Expert Advice, Quality Check, and Final Review. The process opted for conducting thorough research to make authentic business reports is briefly described below-
Secondary Research-
- Based on the understanding of requirements, we conducted secondary research to identify the Segment specifications, qualitative and quantitative data along with the factors responsible for the growth of the market.
- The secondary sources referred for the study include press releases, company annual reports, and research papers related to the industry.
- Various sources such as industry magazines, trade journals, government websites, and associations were also reviewed for gathering precise analysis on opportunities for business expansions in the market.
- Moreover, quantitative as well as qualitative data were also extracted from paid databases, which included Reuters, Factiva, Bloomberg, One Source, and Hoovers, which proved to be useful for in-depth technical study of the market.
Primary Research-
- The research carried out during the desk research was verified by primary interviews. Primary research was scheduled with a number of industry experts for conducting telephonic interviews, and also our team send questionnaires through their official emails.
- The secondary data collected was then verified by various industry participants which included Segment managers, marketing managers, VPs, CEOs, purchasing managers, subject matter experts.
- An interview with the mentioned participants aids invalidation of our research findings regarding the Segment.
- It helps in the provision of first-hand data on factors such as market size, growth, regional trends, market trends, and competition in the industry. This approach makes our findings precise in order to help our clients in strategic decision-making processes.
Subject Matter Advice-
- The secondary and primary research key findings were then validated by the in-house subject matter experts having extensive experience in the market research industry.
- Specific requirements of the clients were reviewed by the experts to check for completion of the market study. Experts help in channelizing the representation skills of the analyst in terms of providing data that can be easily understood by our customers.
Quality Check-
- The analysis done by the research team was further reviewed to check for data accuracy provided to suit the clients’ specific requirements.
- This revision was done in various phases to check the data authenticity and to remove negligible errors in the final compilation.
Final Review-
- After the quality check, a final review of the report was done to look after the presentation, formatting, and to recheck if all the requirements of the clients were addressed. The next phase remains dispatch of the report to the client.
Enquire Before Purchase
Frequently Asked Questions
Why Choose Market Research Strategy?
We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports
We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround
Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.
We abide by the information security policy and adheres to keep your private and business information confidential and secure.